| Primary |
| Contraception |
28.8% |
| Oral Contraception |
18.9% |
| Panic Disorder |
10.6% |
| Menorrhagia |
8.3% |
| Dysmenorrhoea |
3.0% |
| Menstrual Cycle Management |
3.0% |
| Off Label Use |
3.0% |
| Ovarian Failure |
3.0% |
| Convulsion |
2.3% |
| Hypertension |
2.3% |
| Hypovitaminosis |
2.3% |
| Migraine |
2.3% |
| Anxiety |
1.5% |
| Constipation |
1.5% |
| Depression |
1.5% |
| Dermatitis Atopic |
1.5% |
| Endometriosis |
1.5% |
| Hypothyroidism |
1.5% |
| Lung Infection |
1.5% |
| Premenstrual Syndrome |
1.5% |
|
| Pulmonary Embolism |
8.9% |
| Unintended Pregnancy |
8.9% |
| Angiomyolipoma |
6.7% |
| Cerebral Infarction |
6.7% |
| Drug Ineffective |
6.7% |
| Hepatitis Acute |
6.7% |
| Menstruation Delayed |
6.7% |
| Visual Field Defect |
6.7% |
| Abortion Induced |
4.4% |
| Epilepsy |
4.4% |
| Hyperhidrosis |
4.4% |
| Liver Disorder |
4.4% |
| Optic Atrophy |
4.4% |
| Pruritus |
4.4% |
| Urinary Tract Infection |
4.4% |
| Abdominal Pain Upper |
2.2% |
| Androgenetic Alopecia |
2.2% |
| Anxiety |
2.2% |
| Autoimmune Thyroiditis |
2.2% |
| Basal Ganglia Infarction |
2.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
19.7% |
| Contraception |
11.3% |
| Oral Contraception |
11.3% |
| Epilepsy |
7.0% |
| Diabetes Mellitus Non-insulin-dependent |
5.6% |
| Hypertension |
5.6% |
| Off Label Use |
5.6% |
| Hiv Infection |
4.2% |
| Menstrual Cycle Management |
4.2% |
| Obesity |
4.2% |
| Constipation |
2.8% |
| Depression |
2.8% |
| Endometriosis |
2.8% |
| Ovarian Failure |
2.8% |
| Premenstrual Syndrome |
2.8% |
| Anxiety |
1.4% |
| Back Pain |
1.4% |
| Candidiasis |
1.4% |
| Dysmenorrhoea |
1.4% |
| Eye Disorder |
1.4% |
|
| Pulmonary Embolism |
15.2% |
| Cerebrovascular Accident |
12.1% |
| Cerebral Infarction |
6.1% |
| Cytolytic Hepatitis |
6.1% |
| Intracranial Venous Sinus Thrombosis |
6.1% |
| Optic Atrophy |
6.1% |
| Peliosis Hepatis |
6.1% |
| Substance Abuse |
6.1% |
| Abdominal Pain Upper |
3.0% |
| Anxiety |
3.0% |
| Cholestasis |
3.0% |
| Discomfort |
3.0% |
| Dry Eye |
3.0% |
| Dyspnoea |
3.0% |
| Fluid Retention |
3.0% |
| Headache |
3.0% |
| Oedema Peripheral |
3.0% |
| Placental Disorder |
3.0% |
| Polyhydramnios |
3.0% |
| Pregnancy On Oral Contraceptive |
3.0% |
|
| Concomitant |
| Contraception |
17.6% |
| Product Used For Unknown Indication |
8.6% |
| Multiple Sclerosis |
7.8% |
| Depression |
7.5% |
| Anxiety |
6.9% |
| Drug Use For Unknown Indication |
6.1% |
| Parkinson's Disease |
5.5% |
| Gastritis |
4.6% |
| Ankylosing Spondylitis |
4.3% |
| Rheumatoid Arthritis |
3.7% |
| Prophylaxis |
3.5% |
| Hypertension |
3.2% |
| Migraine |
3.2% |
| Colitis Ulcerative |
2.9% |
| Gastric Disorder |
2.9% |
| Oral Contraception |
2.9% |
| Headache |
2.6% |
| Vitamin Supplementation |
2.3% |
| Constipation |
2.0% |
| Diabetes Mellitus |
2.0% |
|
| Weight Increased |
14.8% |
| Weight Decreased |
13.6% |
| Vomiting |
8.6% |
| Cytolytic Hepatitis |
4.9% |
| Dyspnoea |
4.9% |
| Pregnancy |
4.9% |
| Subcutaneous Abscess |
4.9% |
| Abdominal Abscess |
3.7% |
| Headache |
3.7% |
| Hypertension |
3.7% |
| Pituitary Tumour Recurrent |
3.7% |
| Self-injurious Ideation |
3.7% |
| Swelling |
3.7% |
| Treatment Noncompliance |
3.7% |
| Ventricular Fibrillation |
3.7% |
| Withdrawal Syndrome |
3.7% |
| Drug Exposure During Pregnancy |
2.5% |
| Escherichia Urinary Tract Infection |
2.5% |
| Genital Haemorrhage |
2.5% |
| Gingivitis |
2.5% |
|
| Interacting |
| Back Pain |
33.3% |
| Contraception |
33.3% |
| Bipolar I Disorder |
16.7% |
| Oral Contraception |
16.7% |
|
| Mood Swings |
66.7% |
| Pregnancy On Contraceptive |
33.3% |
|
